Sanctuary Advisors LLC Purchases Shares of 11,901 Abrdn Life Sciences Investors (NYSE:HQL)

Sanctuary Advisors LLC acquired a new position in Abrdn Life Sciences Investors (NYSE:HQL) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 11,901 shares of the company’s stock, valued at approximately $154,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Cetera Advisors LLC purchased a new position in shares of Abrdn Life Sciences Investors in the 1st quarter worth $1,929,000. Oppenheimer & Co. Inc. grew its stake in shares of Abrdn Life Sciences Investors by 4.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 18,414 shares of the company’s stock worth $251,000 after buying an additional 814 shares in the last quarter. B. Riley Wealth Advisors Inc. purchased a new position in shares of Abrdn Life Sciences Investors in the 1st quarter worth $143,000. Future Financial Wealth Managment LLC purchased a new position in shares of Abrdn Life Sciences Investors in the 1st quarter worth $27,000. Finally, Wedbush Securities Inc. grew its stake in shares of Abrdn Life Sciences Investors by 8.2% in the 2nd quarter. Wedbush Securities Inc. now owns 16,673 shares of the company’s stock worth $236,000 after buying an additional 1,261 shares in the last quarter. 32.21% of the stock is owned by hedge funds and other institutional investors.

Abrdn Life Sciences Investors Price Performance

Shares of NYSE:HQL opened at $15.20 on Monday. Abrdn Life Sciences Investors has a 52 week low of $11.34 and a 52 week high of $15.90. The firm has a fifty day simple moving average of $15.16 and a two-hundred day simple moving average of $14.41.

Abrdn Life Sciences Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Friday, August 23rd were paid a dividend of $0.49 per share. The ex-dividend date was Friday, August 23rd. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48. This represents a $1.96 dividend on an annualized basis and a dividend yield of 12.89%.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.